spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Gate Pharmaceuticals 

 HSMN NewsFeed - 25 Sep 2019
Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 12 Jun 2019
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Feb 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 7 Feb 2017
EyeGate Pharmaceuticals Announces Executive Promotions
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 10 May 2016
Praveen Tyle, Ph.D. Joins Lexicon As Executive Vice President Of Research And Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2013
Osmotica Pharmaceutical Announces the Appointment of Senior Industry Executive Praveen Tyle, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2011
EyeGate Pharma Secures Additional $5.9M Series D Venture Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 29 Apr 2010
EyeGate Pharma Establishes Research Collaboration With GlaxoSmithKline to Deliver Medicines Using the EyeGate(R) II Delivery System
Devices Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 8 Jan 2010
EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Dec 2007
Lannett Receives FDA Approval for Phentermine
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jan 2007
EyeGate Pharma Closes $12M Series B Venture Financing
Biopharmaceuticals Venture Capital Personnel
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
Gate Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.